Citation Impact
Citing Papers
A new taxonomy for describing and defining adherence to medications
2012 Standout
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Switching From Clozapine to Zotepine in Patients With Schizophrenia
2013
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
1997
Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight
1998
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States
2007 Standout
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
Predicting Medication Noncompliance After Hospital Discharge Among Patients With Schizophrenia
2000
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia
2002 Standout
Compliance With Medication Regimens for Mental and Physical Disorders
1998
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia
2000
Non-Compliance With Treatment in Patients Suffering From Schizophrenia: a Study To Evaluate Possible Contributing Factors
1998
A review of central 5-HT receptors and their function
1999 Standout
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
2003 Standout
How stigma interferes with mental health care.
2004 Standout
Serotonergic basis of antipsychotic drug effects in schizophrenia
1998
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia
2005
The role of 5-HT2A receptors in antipsychotic activity
1995
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
A prospective evaluation of adherence to medication in first episode schizophrenia
2006
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
2007
Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
2006
Sexuality and Schizophrenia: A Review
2004
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication
2002
Adherence to Medication
2005 Standout
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia
1997
Sexual dysfunction: the unspoken side effect of antipsychotics
1998
A glutamatergic deficiency model of schizophrenia
1999 StandoutNobel
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
A systematic review of randomized controlled trials that attempt to identify interventions that improve patient compliance with prescribed antipsychotic medication
2000
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Sexual dysfunction: The unspoken side effect of antipsychotics
1998
The role of serotonin in the pathophysiology and treatment of schizophrenia
1997
Hallucinogens
2004 Standout
Works of Fleischhacker Ww being referenced
Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin.
1990
Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
1989
Compliance with antipsychotic drug treatment: influence of side effects
1994